✦ LIBER ✦
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma
✍ Scribed by John M. Kirkwood; John Wilson; Theresa L. Whiteside; Sandra Donnelly; Ronald B. Herberman
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 316 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.